Skip to main content

Table 2 Clinical Characteristics of NAFLD+CHD Patients and NAFLD Patients

From: TRIB1 rs17321515 gene polymorphism increases the risk of coronary heart disease in general population and non-alcoholic fatty liver disease patients in Chinese Han population

Parameters

NAFLD+CHD (n = 156)

NAFLD (n = 146)

Statistics

P value

Male/Female

76/80

81/65

χ2 = 0.421

0.516

Age, y

64.00 (59.00, 72.75)

64.00 (45.00, 74.00)

Z = − 0.644

0.520

BMI, kg/m2

25.47 (23.05, 27.68)

26.35 (24.86, 28.49)

Z = −3.431

0.001

ALT, U/L

23.58 (16.07, 34.36)

22.67 (18.30, 35.68)

Z = − 0.919

0.358

AST, U/L

21.29 (16.80, 32.02)

21.55 (18.38, 28.09)

Z = − 0.647

0.517

GGT, U/L

30.70 (21.31, 42.67)

32.55 (20.97, 47.79)

Z = − 0.986

0.324

ALP, U/L

79.52 (66.58, 96.46)

68.48 (59.09, 81.81)

Z = −3.124

0.002

TG, mmol/L

1.58 (1.13, 2.18)

1.54 (1.16, 2.21)

Z = −0.145

0.885

TC, mmol/L

4.64 (3.75, 5.54)

5.42 (4.98, 6.02)

Z = −1.682

0.093

HDL, mmol/L

1.02 (0.88, 1.12)

1.19 (1.05, 1.32)

Z = −6.741

< 0.001

LDL, mmol/L

2.86 (2.10, 3.45)

3.30 (2.97, 3.52)

Z = − 1.332

0.183

TBIL, μmol/L

12.70 (9.70, 16.77)

12.00 (10.00, 14.90)

Z = − 0.842

0.040

FPG, mmol/L

5.70 (4.68, 6.96)

4.96 (4.52, 5.79)

Z = −3.503

< 0.001

  1. Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; FPG, fasting plasma glucose; GGT, γ-glutamyltransferase; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TBIL, total bilirubin; TC, total cholesterol; TG, triglyceride